Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
This entry does not correspond to a defined molecule, receptor, enzyme, transporter, or gene, but rather refers to a therapeutic principle central to Traditional Chinese Medicine (TCM) aiming to remedy "blood stasis" by promoting blood circulation. TCM achieves these effects through herbal medicines, acupuncture, and other therapies, targeting system-level processes such as improved hemodynamics, microvascular integrity, and balanced platelet activity. These interventions have been used in the context of cardiovascular diseases, diabetes complications, chronic kidney disease, and cancer, but mapping this principle to a canonical molecular target is inappropriate. Numerous herbs and compounds are cited as "blood circulation promoting" but should be referenced individually if a molecular target is needed. Modern drugs like aspirin and heparin overlap with some mechanistic underpinnings in TCM.
Improve microcirculation, inhibit platelet aggregation, modulate TXA₂/PGI₂ balance, protect vascular endothelium, inhibit Na⁺/K⁺-ATPase (leading to increased myocardial contractility), reduce oxidative stress, and regulate lipid metabolism
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Blood circulation promotion in TCM theory.